未登录 Peripheral Retinal Vascular Biomarkers on Tomography Angiography for Severity Grading in Retinitis Pigmentosa 视网膜周边血管成像血管生物标志物在视网膜色素变性严重程度分级中的应用 Jiao, Yutian; Jiang, Jingwen; Chen, Zhixuan; Lin, Bing; Wang, Hong; Hang, Chenyue; Zhang, Ting; Wan, Xiaoling; Li, Jianqing; Zhao, Tianyuan; Zhou, Hao; Jiang, Xujun; Xia, Weiqiao; Li, Tong; Sun, Junran; Liu, Xinxin; She, Xiangjun; Zhang, Yun; Jia, Huixun; Gong, Yuanyuan; Li, Jingming; Yu, Suqin; Chen, Jieqiong; Sun, Xiaodong 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Intravitreal Gene Therapy with LX102-C01 in Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study of 12-Month Safety and Efficacy Outcomes Sun, Junran; Shen, Mengxi; Chen, Jieqiong; Wu, Yidong; Zhou, Yanping; Feng, Jingyang; Cheng, Yuxuan; Jia, Huixun; Yang, Xiaolu; Gong, Yuanyuan; Liu, Yang; Wang, Hong; Wang, Ruikang K.; Rosenfeld, Philip J.; Li, Tong; Wang, Fenghua; Sun, Xiaodong 分享 收藏
Contribution of ferroptosis and SLC7A11 to light-induced photoreceptor degeneration Huang, Xiaoxu; Zhang, Yumeng; Jiang, Yuxin; Li, Tong; Yang, Shiqi; Wang, Yimin; Yu, Bo; Zhou, Minwen; Zhang, Guanran; Zhao, Xiaohuan; Sun, Junran; Sun, Xiaodong 分享 收藏
分享 收藏
分享 收藏
Generation of the induced pluripotent stem cell line SJTUGHi004-A derived from a Best's disease patient with c.763C > T mutation in BEST1 gene (vol 88, 103806, 2025) 来源于Best's病患者的c.763C > T突变BEST1基因诱导多能干细胞系SJTUGHi004-A的建立 (vol 88, 103806, 2025) Jiang, Yuxin; Wang, Hong; Jiang, Lihong; Chen, Jieqiong; Li, Tong; Zhang, Guanran; Chen, Xueli; Jiang, Mei; Sun, Xiaodong 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Association of nonrefractive visual impairment with risk of all-cause and specific-cause mortality in the National Health and Nutrition Examination Survey, 1999 to 2008 2008年1999年全国健康和营养检查调查中非屈光性视力损害与全因和特因死亡率风险的关联 Gui, Siyu; Wang, Xinchen; Wang, Qianqian; Zhong, Lan; Qiao, Jianchao; Xu, Yueyang; Li, Yiran; Huang, Zhihao; Hu, Chengyang; Tao, Fangbiao; Sun, Xiaodong; Liu, Heting; Gao, Jie 分享 收藏
分享 收藏
分享 收藏
Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II Trial Efdamrofusp alfa与Aflibercept在新生血管性年龄相关性黄斑变性患者中的疗效与安全性:一项随机、双盲、活性对照、非劣效性、II期临床试验 Sun, Junran; Song, Yanping; Gong, Yuanyuan; Tao, Liming; Wang, Hong; Shu, Xiangwen; Wen, Ying; Cui, Ling; Ye, Jian; Lu, Shujie; Deng, Junjie; Li, Haoyu; Xu, Yihua; Qian, Lei; Wu, Zhifeng; Bi, Yanlong; Liu, Qinghuai; Xu, Xiangzhong; Wu, Miaoqin; Zhang, Jinglin; Hao, Jilong; Tong, Jianping; Dai, Hong; Wang, Feng; Zhao, Mingwei; Mao, Junfeng; Li, Chaopeng; He, Tao; Pei, Cheng; Liu, Xiaoling; Wang, Xian; Li, Mingxin; Wang, Wei; Zheng, Qinxiang; Guan, Huaijin; Peng, Hui; Fan, Ke; Zhang, Wenfang; Zhu, Dan; Yu, Songping; Wei, Wenbin; Ding, Lin; Li, Jinying; Lu, Peirong; Yan, Ming; Liu, Wei; Jia, Huixun; Sun, Xiaodong 分享 收藏
分享 收藏
Efficacy, durability and safety of faricimab for patients with neovascular age-related macular degeneration: 48-week results from the phase 3 LUCERNE China subpopulation Zou, Wenjun; Jiang, Qin; Wang, Yanling; Wei, Wenbin; Sun, Xiaodong; Basu, Karen; Chen, Qiuyu; Kotecha, Aachal; Li, Sijing; Liu, Ruyuan; Patel, Vaibhavi; Chen, Youxin 分享 收藏